Insider filing
Traded Sep 14 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Aug 25, 2026 · Filed Sep 2, 2026
The CEO of Exozymes paid $1.9K out of pocket for Exozymes shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$1,880
Shares × reported transaction price
<$25K
+1.8%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $7.53 on Aug 25, 2026, 71% above its 52-week low and 54% below its high, after an 8% rise over the previous 30 trading days
52-week range $4.40 (Jul 28, 2026) to $16.50 (Nov 12, 2025), 26% of the way up, from 237 adjusted closes. 30 trading days earlier: $7.00 on Jul 14, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The first open-market purchase by any EXOZ insider since Jul 2025
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −9.3% | −2.0% | −7.3% |
| 30 days | −18.8% | +0.2% | −19.0% |
Past results only. Not a forecast.
Insider filing
Traded Sep 14 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
Traded Aug 26 · filed 7 days later
The CEO of Exozymes paid $30 out of pocket for Exozymes shares.
Insider buying
Traded Aug 26 · filed 7 days later
The CEO of Exozymes paid $1.8K out of pocket for Exozymes shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.